Global Liquid Biopsy Market is expected to be US$ 3.1 Billion by 2026.

1
Liquid Biopsy Market
Liquid Biopsy Market
2
Report Description and Highlights
A liquid biopsy is an emerging tool for the
diagnosis of cancer disease nowadays. The liquid
biopsy involves collecting samples and analysing
tumours in the blood to diagnose cancer disease
in the human body. Liquid biopsy assists medical
practitioners as a source of genomic and
proteomic knowledge in cancer patients by early
detection of circulating tumour cells, DNA and
extracellular vesicles. Currently, liquid biopsy
plays a critical role in accelerating and
implementing accurate oncology in clinical
settings by leading to an improved understanding
of tumour heterogeneity and allowing for dynamic
control of reactions to care and variations in
genomics. According to Renub Research analysis,
Global Liquid Biopsy Market is expected to be US
3.1 Billion by 2026.
Liquid Biopsy Market
3
Liquid Biopsy Market
The major growth drivers of liquid biopsies are
that while extracting the tissue sample from the
human body is much pain-free, it substitutes the
pain associated with the procedure. Besides,
liquid biopsy is very accurate in detecting
tumour cells in the blood of cancer patients. Due
to the low sensitivity of liquid biopsy, it acts
as the restraint factor in the market's
growth. The key players play an essential role
in the liquid biopsy market's growth by launching
innovative products. In June 2020, NeoGenomics
Inc. launched three liquid biopsy tests for
non-small cell lung cancer, solid tumour types,
and specific breast cancer. The COVID-19 effect
in the liquid biopsy market has been harsh
because all patients are taking therapies to
treat cancer since they have a weak immune
system, and they are less prone to fight with
coronavirus diseases.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lliquid-biopsy-market-p.php
Liquid Biopsy Market
4
Liquid Biopsy Market
Renub Research report titled Liquid Biopsy
Market Global Forecast by Cancer (Breast Cancer,
Lung Cancer, Prostate Cancer, Colorectal Cancer
Others), Product (Kits Consumables, Instruments
and Services), Sample (Plasma/Serum, Urine
Others), Circulating Biomarkers (Circulating
Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs)
Exosomes), Clinical Application (Monitoring,
Theranostics, Prognosis Screening), Regions
(Europe, North America, Latin America,
Asia-Pacific and Middle East/Africa), Companies
(Roche Diagnostics, Thermo Fisher Scientific
Inc., Biocept Inc., Bio-Rad Laboratories Inc.,
Genomic Health, Biocartis, Myriad Genetics Inc.,
Qiagen, NeoGenomics Laboratories) provides a
detailed analysis of Global Liquid Biopsy
Industry.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlunited-states-specialty-pharmaceuticals-market
-p.php
Liquid Biopsy Market
5
Liquid Biopsy Market
By Cancer 1.    Lung Cancer 2.    Breast
Cancer3.    Colorectal Cancer 4.    Prostate
Cancer5.    Others By Product 1.    Kits
Consumables 2.    Instruments3.    Services By
Circulating Biomarkers 1.    Circulating Tumor
Cells (CTCs)2.    Circulating Tumor DNA
(ctDNA)3.     Extracellular Vesicles4.    Others
Liquid Biopsy Market
6
Liquid Biopsy Market
Liquid Biopsy Market Share () - by Regions
Forecast (2021 - 2026)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
report
Liquid Biopsy Market
7
Liquid Biopsy Market
By Sample 1.    Plasma/Serum 2.    Urine3.  
 Others By Clinical Application 1.  
 Monitoring 2.    Prognosis3.  
 Theranostics 4.    Screening By Regions 1.  
 North America 2.    Europe3.  
 Asia-Pacific 4.    Latin America5.    Middle
East/Africa
Liquid Biopsy Market
8
Liquid Biopsy Market
All the 9 Companies Studied in the Report have
been Studied from three Points     Company
Overview     Recent Development    Financial
Insight By Companies 1.    Thermo Fisher
Scientific Inc.2.    Roche Diagnostics3.  
 Bio-Rad Laboratories Inc.4.    Biocept
Inc.5.    Biocartis6.    Myriad Genetics,
Inc.7.    Genomic Health8.    NeoGenomics
Laboratories9.    Qiagen
Liquid Biopsy Market
9
Liquid Biopsy Market
Liquid Biopsy Market
10
Contact Us
Liquid Biopsy Market